$80.54+0.59 (+0.74%)
National Health Investors, Inc.
National Health Investors, Inc. in the Real Estate sector is trading at $80.54 with a market capitalization of $3.4B. Wall Street consensus targets $82.88 (8 analysts), implying a +2.9% move over the next 12 months. The stock is currently 12% below its 52-week high of $91.38, remaining 4.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $115.13Mβ | $105.82Mβ | $89.85Mβ | $90.66Mβ | $89.30M |
| Gross Profit | $112.33Mβ | $103.25Mβ | $87.24Mβ | $87.75Mβ | $86.41M |
| Operating Income | $52.09Mβ | $50.23Mβ | $44.08Mβ | $48.66Mβ | $47.88M |
| Net Income | $40.10Mβ | $38.16Mβ | $32.86Mβ | $36.99Mβ | $34.16M |
National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical facility investments. NHI's por...
EastGroup Properties (EGP) delivered FFO and revenue surprises of -0.42% and -0.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Rexford Industrial (REXR) witnessed a jump in share price last session on above-average trading volume. The latest trend in FFO estimate revisions for the stock doesn't suggest further strength down the road.
SHO vs. NHI: Which Stock Is the Better Value Option?
SHO vs. NHI: Which Stock Is the Better Value Option?
Recent performance and income profile National Health Investors (NHI) has drawn attention after a recent share price pullback, with the stock down about 3% over the past day, 4% over the past week and month, and 16% over the past 3 months. The company operates as a self managed real estate investment trust focused on senior housing and medical facilities in the United States. It generates US$404.711m in revenue and US$147.887m in net income across its portfolio. See our latest analysis for...